28P Long-term survival and treatment (tx) patterns in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced NSCLC treated with first-line (1L) osimertinib (osi): German cohort of a global real-world (rw) observational study

F Griesinger,S Zacharias,P Steffens,R Schuh,P Hindocha,M Cooper,J Chapaneri,R.J-B Salomonsen,P.S Karia,M Thomas

doi:10.1016/j.esmoop.2024.102607

28P Long-term survival and treatment (tx) patterns in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced NSCLC treated with first-line (1L) osimertinib (osi): German cohort of a global real-world (rw) observational study

F Griesinger, S Zacharias + Show 8 more

Open Access

https://doi.org/10.1016/j.esmoop.2024.102607

Copy DOI

Journal: ESMO open	Publication Date: Mar 1, 2024
License type: cc-by-nc-nd

#Epidermal Growth Factor Receptor #Mutation-positive Advanced NSCLC + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

28P Long-term survival and treatment (tx) patterns in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced NSCLC treated with first-line (1L) osimertinib (osi): German cohort of a global real-world (rw) observational study

Full Text